| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |